Tharimmune, Inc.
THAR| Date | Action | ETF | Shares | Close | Est. total |
|---|---|---|---|---|---|
| 26.02.17 | BUY | ARKF | 14,675 | $4.74 | $69.6K |
| 26.02.13 | BUY | ARKF | 3,540 | $4.48 | $15.9K |
| 26.02.12 | BUY | ARKF | 24,430 | $4.28 | $104.6K |
| 26.02.11 | BUY | ARKF | 31,808 | $4.35 | $138.4K |
| 26.02.09 | BUY | ARKF | 54,600 | $4.37 | $238.6K |
| 26.02.06 | BUY | ARKF | 56,187 | $4.14 | $232.6K |
Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
Analyst Consensus
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Price Information
Trading Volume
Valuation
Financials
Profitability
Dividend
Technical
Tharimmune, Inc. is a company focused on advancing institutional blockchain adoption and the digitization of financial markets through its Canton Coin and network support. It also engages in clinical-stage biotechnology research and development. Previously known as Hillstream BioPharma, the company aims to bridge the gap between blockchain technology and traditional finance.
AI-generated summary. Not investment advice.
Related ARK stocks
Explore companies with similar themes or neighboring ARK trading activity.